[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359682-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359682-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-p2x4-purinergic-receptor-controls-the-autophagy-related-release-of-small-extracellular-vesicles-from-mammary-cancer-cells-under-hypoxia","The P2X4 purinergic receptor controls the autophagy-related release of small extracellular vesicles from mammary cancer cells under hypoxia","","Small extracellular vesicles (sEVs) are key mediators of cell communication and respond to cellular stress. This study tests how P2X4 and P2X7 purinoreceptors regulate sEV biogenesis and release from triple-negative mammary cancer cells under hypoxia. Using CRISPR/Cas9 knockdown and selective pharmacology, intracellular compartments are examined and sEV release is quantified with nanoparticle tracking, proteomics, and western blotting. Functional uptake and effects on invasiveness are assessed in recipient cancer cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-p2x4-purinergic-receptor-controls-the-autophagy-related-release-of-small-extracellular-vesicles-from-mammary-cancer-cells-under-hypoxia/359682/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-p2x4-purinergic-receptor-controls-the-autophagy-related-release-of-small-extracellular-vesicles-from-mammary-cancer-cells-under-hypoxia/359682.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on P2X receptors?","Question",{"text":63,"@type":64},"The study investigates whether P2X4 and P2X7 regulate the biogenesis and release of small extracellular vesicles (sEVs) from triple-negative mammary cancer cells under hypoxia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were P2X4 and P2X7 functionally tested in the research?",{"text":68,"@type":64},"P2X4 or P2X7 receptors were knocked down or inhibited using CRISPR/Cas9 models in 4T1 triple-negative mammary cancer cells plus selective pharmacology.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show regarding autophagy-related sEV secretion under hypoxia?",{"text":72,"@type":64},"P2X4, but not P2X7, controls sEV release under hypoxia. P2X4 silencing increases multivesicular bodies and sEV production, shifts sEV cargo toward autophagy-related proteins, and suggests unconventional secretion via amphisomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359682,1790208498,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":33,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Duret etal. Cell Communication and Signaling (2026) 24:247  \n[https://doi.org/10.1186/s12964-026-02811-5](https://doi.org/10.1186/s12964-026-02811-5)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nThe P2X4 purinergic receptor controls the autophagy-related release of small extracellular vesicles from mammary cancer cells under hypoxia  \nThomas Duret1, Mohammed Elmallah1, Audrey Heraud-Meley1, Cloé Tessier1, Ana Valeria Vinhais Da Silva1, Stéphanie Chadet1, Roxane Lemoine2, Justine Gainche1, Valérie Labas3,4, Ana-Paula Teixeira-Gomes3,4,  \nDaniel Tomas3,4, Vesna Cuplov1, Lin-Hua Jiang1,5,6, Lili Fan1,7, Gang Yin1,7, Christophe Baron1,8,9 and Sébastien Roger 1,9*  \nAbstract  \nBackground Small extracellular vesicles (sEVs) are critical mediators of cell communications and are influenced by cellular stress. This study investigates the role of P2X4 and P2X7 purinoreceptors in the biogenesis and release of sEVs from triple-negative mammary cancer cells under hypoxia.  \nMethods In this study, we used CRISPR/Cas9 knockdown models from the triple-negative mammary cancer cell line 4T1 and selective pharmacology, to knock-down or inhibit either P2X4 or P2X7 receptors. We analysed intracellular endo-lysosomal compartments with transmission electron microscopy and epifluorecence imaging. The release and characterization of sEVs was analysed by nanoparticle tracking analysis, proteomics and western blotting. The incorporation of sEVs into recipient cells was followed by epifluorescent imaging and flow cytometry and consequences on cancer cell invasiveness was studied using transwell assays.  \nResults We found that P2X4 but not P2X7 regulates sEV release. P2X4 silencing increased the number of multivesicular bodies (MVBs), enhanced sEV production and selectively promoted CD9-positive sEV subpopulations under hypoxia. Proteomic analysis revealed altered sEV protein content in P2X4-deficient cells, including enrichment in epithelial markers and autophagic proteins (LC3-II, p62), and depletion of the endosomal sorting complexes required for transport (ESCRT) components required for endo-lysosomal fusion. This profile indicates a shift toward autophagy-dependent, unconventional sEV secretion via amphisomes. Additionally, sEVs from P2X4-deficient cells integrated more efficiently into recipient cancer cells but decreased their invasive capacity, suggesting functional consequences of altered sEV cargo. In contrast, intervention of P2X7 had no impact on sEV release.  \nConclusions Overall, our findings identify the P2X4 receptor as a key regulator of hypoxia-induced sEV secretion and composition through modulation of endo-lysosomal trafficking and autophagy, with potential implication for tumour progression and intercellular signalling.  \n*Correspondence:  \nSébastien Roger [sebastien. roger@univ-tours.fr](sebastien. roger@univ-tours.fr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/license","cbCaitC7Ed9OwZPm","https://ap.wps.com/l/cbCaitC7Ed9OwZPm","pdf",3369867,24,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of the study on P2X receptors?\",\"answer\":\"The study investigates whether P2X4 and P2X7 regulate the biogenesis and release of small extracellular vesicles (sEVs) from triple-negative mammary cancer cells under hypoxia.\"},{\"question\":\"How were P2X4 and P2X7 functionally tested in the research?\",\"answer\":\"P2X4 or P2X7 receptors were knocked down or inhibited using CRISPR/Cas9 models in 4T1 triple-negative mammary cancer cells plus selective pharmacology.\"},{\"question\":\"What did the results show regarding autophagy-related sEV secretion under hypoxia?\",\"answer\":\"P2X4, but not P2X7, controls sEV release under hypoxia. P2X4 silencing increases multivesicular bodies and sEV production, shifts sEV cargo toward autophagy-related proteins, and suggests unconventional secretion via amphisomes.\"}]","The P2X4 purinergic receptor controls the autophagy-related release of small extracellular vesicles from mammary cancer cells under hypoxia | PDF",1790137534,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc2707e268384b66d104d4b22fc7bcaa.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/403afa5ce3c9b5447b9b8b680e0c8b61.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b79b0046f97126d09ebf02e36126cbcb.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7ea624c496741ff017417affbeb2dcf.webp",980,1306]